Skip to Content
Merck
CN

901459

Sigma-Aldrich

Allyl poly(ethylene glycol)-block-poly(lactide-co-glycolide)

PEG average Mn 5000, PLGA average Mn 15000, lactide:glycolide (50:50)

Synonym(s):

Allyl-PEG-b-PLGA, Allyl-PEG-PLGA

Sign Into View Organizational & Contract Pricing

Select a Size

About This Item

Linear Formula:
C3H5O(C2H4O)n[(C2H2O2)x(C3H4O2)y]m
UNSPSC Code:
51171641
NACRES:
NA.23

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

Feed Ratio: 50:50+/-5 (Lactide:Glycolide, by NMR)
Identity: Conforms to structure (by NMR)

form

powder

feed ratio

lactide:glycolide (50:50)
lactide:glycolide±5 (50:50)

mol wt

PEG Mn 4000-6000 g/mol (NMR)
PEG average Mn 5000
PLGA Mn 13500-16500 g/mol (NMR)
PLGA average Mn 15000

color

white

storage temp.

−20°C

Application

Allyl poly(ethylene glycol)-block-poly(lactide-co-glycolide) is an allyl-functionalized, biocompatible, amphiphilic block copolymer. Due to its self-assembling properties, this material can be used in the formation of nanoparticles for drug delivery. Additionally, due to the allyl-functionalization of the PEG block, this material can be used to covalently conjugate biomolecules, API, or targeting ligands rapidly. Potential uses include the targeted and/or controlled release of cancer drugs, anti-inflammatory drugs, antibiotics, or anaesthetic agents.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

>230.9 °F

Flash Point(C)

> 110.5 °C

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCN6798
MKCG2644

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories.
Xu Y, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials, 105, 1692-1716 (2017)
Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties and nanomedical applications as drug delivery system.
Locatelli E, et al.
Journal of Nanoparticle Research, 14, 1316-1316 (2012)
Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties and nanomedical applications as drug delivery system
Locatelli E, et al
Journal of Nanoparticle Research, 14, 1316-1316 (2012)
Ilaria Monaco et al.
Journal of medicinal chemistry, 60(10), 4510-4516 (2017-05-05)
Polymeric nanoparticles (PNPs) may efficiently deliver in vivo therapeutics to tumors when conjugated to specific targeting agents. Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor β and can cross the blood-brain barrier (BBB). We synthesized Gint4.T-conjugated PNPs able of high

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service